Pure unit-conversion math for Semaglutide (mg → mcg → IU on a U-100 insulin syringe). Half-life steady-state graph, cost-per-mcg comparator, shareable URL. Research use only — no clinical recommendations.
→ Open the Semaglutide calculatorSemaglutide is a GLP-1 receptor agonist with a plasma half-life around seven days, supporting once-weekly administration. FDA-approved as Ozempic, Wegovy, and Rybelsus. The 39% lean-mass-loss number from Harvard Science Review is the contested literature point.
Want the deep-dive? The Compound Brief covers Semaglutide mechanism, half-life math, and what the literature actually shows in the Sunday issue. Subscribe (free) →
Verify your vendor: See Semaglutide COA scores at /coa-index.